For a number of years this laboratory has been interested in the effects of abused substances on neurochemical and behavioral systems. The attempt has been to be able to correlate drug dosage (tissue concentration of the drug) with behavioral and biochemical manifestation in an attempt to delineate mechanisms. Research with the popular drug phencyclidine (angel dust) has demonstrated an interaction with catecholamine and cholinergic systems. Since these systems, particularly dopaminergic, have been demonstrated to play a strong role in hormonal regulation, we have chosen to hypothesize that PCP may 1) influence catecholamine systems in vivo as they have been found to do in vitro and 2) influence hormonal regulation. Sensitive neurochemical assays of endogenous amine release and radioimmune assays of prolactin will be employed to test these hypotheses. Since it is possible that PCP metabolites and/or the influences of PCP on catecholaminergic systems may mediate some of the drug's effects on cholinergic systems, we plan to utilize brain lesion and neurochemical analyses to examine this possibility. The findings of this research should provide 1) further insight into the sequelae of drug administration, 2) further information about the mechanisms of drug action, and possibly 3) information of importance to clinicians dealing with PCP abusers.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003355-02
Application #
3207835
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1984-09-01
Project End
1987-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Boggan, W; Middaugh, L (1989) Effect of central injection of phencyclidine on QNB accumulation and motor activity. Eur J Pharmacol 166:123-9
Boggan, W O; Monroe, B; Turner Jr, W R et al. (1989) Effect of prenatal ethanol administration on the urogenital system of mice. Alcohol Clin Exp Res 13:206-8
Boggan, W O; Ondo, J G (1989) Effect of central administration of phencyclidine on plasma concentrations of luteinizing hormone. Brain Res 478:382-4
Boggan, W O; Middaugh, L D; Faught, K (1989) Effect of dopaminergic drugs on enhancement of the binding of quinuclidinyl benzilate by phencyclidine in vivo. Neuropharmacology 28:617-24
Boggan, W O; Faught, K; Boyd, S et al. (1988) Parametric studies on phencyclidine enhancement of 3H quinuclidinyl benzilate accumulation in vivo. Pharmacol Biochem Behav 30:31-5
Middaugh, L D; Favara, J P; Boggan, W O et al. (1988) Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites. Psychopharmacology (Berl) 96:381-4
Boggan, W O; Middaugh, L D (1987) Doubtful role for phencyclidine metabolites in PCP enhancement of QNB binding. Pharmacol Biochem Behav 26:671-6
Boggan, W O; Stringer, A J; Faught, K et al. (1987) Effect of phencyclidine and two monohydroxy metabolites on 3H QNB binding in vivo in rats. Pharmacol Biochem Behav 26:847-9